Get in touch.

List of contacts

Do you have any questions about ZB MED`s services or the range of literature we offer? Or maybe you need some tips on how to run searches in LIVIVO?

Contact

info@zbmed.de
Phone: +49 (0)221 999 892 240

Cologne Site

Medicine and Health

Address:
ZB MED – Information Centre for Life Sciences
Gleueler Straße 60
50931 Cologne (Köln)
Germany

Bonn Site

Nutritional, Environmental and Agricultural Sciences

Address:
ZB MED – Information Centre for Life Sciences
Friedrich-Hirzebruch-Allee 4
53115 Bonn
Germany

InfoCenter

INFORMATION.

KNOWLEDGE.
LIFE.

An infrastructure and research centre for data and information in the life sciences.

Studying or working in life sciences?

We've got the research tools you need.

Conference detail

Conference details

21.02.2018 - 22.02.2018

RNA Therapeutics

Location
Holiday Inn Kensington Forum, 97 Cromwell Road, London, SW7 4DN
Contact

Pav Solanki

psolanki@smi-online.co.uk

+442078276048

Country
United Kingdom
Subject area(s)
Shortinfo

One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and evaluate with key industry leaders the lessons they’ve learnt whilst developing an RNA therapeutic.


Join us this February 2018, as SMi's RNA Therapeutics Conference brings together industry experts from leading RNA therapeutics companies to analyze and evaluate the latest advancements including SaRNA as a potential therapeutic for people with liver cancer, advances in targeted delivery of nucleotides beyond the liver and the latest developments in delivery systems, such as exosomes and nanocomplexes. www.therapeutics-rna.com/evvnt


How Will You Benefit?


Network and learn from leading professionals such as:


- Nagy Habib, Head of HPB Surgery, Imperial College London and Co-Founder, MiNA Therapeutics

- Shalini Andersson, Senior Director Drug Metabolism and Pharmacokinetics, AstraZeneca RandD

- Ekkehard Leberer, Senior Director, Sanofi

- Jeffrey Ulmer, Head Preclinical RandD, GSK

- James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals

- Mariola Fotin-Mleczek, Chief Scientific Officer, CureVac

- Bob D. Brown, Chief Scientific Officer and Senior Vice President, Research, Dicerna Pharmaceuticals

- Oliver Rausch, VP Research and Development, Storm Therapeutics

- Kirsty Wydenbach, Senior Medical Assessor, Deputy Unit Manager, Clinical Trials Unit, MHRA


Some Featured Highlights will include:


- Hear from MiNA Therapeutics about their new pre-clinical data supporting the on-target mechanism of action of their pioneering new drug candidate MTL-CEBPA

- Learn how CureVac's sophisticated technologies and approaches have helped overcome limitations such as the instability of single-stranded RNA

- Discover STORM Therapeutics' innovative approach: Harnessing the power of RNA epigenetics to develop first-inclass drugs in oncology.